isoniazid and orlistat
isoniazid has been researched along with orlistat in 9 studies
Research
Studies (9)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Camoin, L; Canaan, S; Cavalier, JF; Durand, T; Spilling, CD | 1 |
| Balor, S; Besra, GS; Bifani, P; de Chastellier, C; Dobson, G; Gibson, KJ; Gorvel, JP; Kremer, L; Locht, C; Minnikin, DE | 1 |
| Harinath, BC; Hutke, V; Misra, AK; Varma, SK; Waghmare, PJ; Wankhade, G | 1 |
| Harinath, BC; Hutke, V; Waghmare, PJ; Wankhade, G | 1 |
Reviews
2 review(s) available for isoniazid and orlistat
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Lipolytic enzymes inhibitors: A new way for antibacterial drugs discovery.
Topics: Antitubercular Agents; Carboxylic Ester Hydrolases; Drug Design; Enzyme Inhibitors; Humans; Lactones; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycolic Acids; Organophosphorus Compounds; Orlistat; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2021 |
Other Studies
7 other study(ies) available for isoniazid and orlistat
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Identification and structural characterization of an unusual mycobacterial monomeromycolyl-diacylglycerol.
Topics: Anti-Obesity Agents; Antitubercular Agents; Diglycerides; Drug Design; Enzyme Inhibitors; Fatty Acid Synthases; Isoniazid; Lactones; Lipids; Magnetic Resonance Spectroscopy; Molecular Structure; Mycobacterium kansasii; Orlistat; Spectrometry, Mass, Electrospray Ionization; Triglycerides | 2005 |
Inhibitory effect of isoniazid and orlistat combination on mycobacterial ES-31 serine protease in vitro and on the growth of M.tb bacilli in axenic culture.
Topics: Antitubercular Agents; Axenic Culture; Drug Combinations; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Humans; Isoniazid; Lactones; Mycobacterium tuberculosis; Orlistat; Serine Proteases | 2012 |
Elisa protocol for rapid screening of potential anti-tubercular drugs based on antigenic reactivity of mycobacterial ES-31 serine protease - a drug target supported by axenic culture of Mycobacterium tuberculosis H37 Ra strain in the presence of inhibitor
Topics: Antitubercular Agents; Axenic Culture; Bacterial Proteins; Drug Resistance, Microbial; Enzyme-Linked Immunosorbent Assay; Humans; Isoniazid; Lactones; Mycobacterium tuberculosis; Orlistat; Serine Proteases; Tuberculosis | 2013 |